{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T13:12:05Z","timestamp":1767964325814,"version":"3.49.0"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,3,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>There is a need for vaccines that can confer broad immunity against highly diverse pathogens, such as influenza. The efficacy of conventional influenza vaccines is dependent on accurate matching of vaccines to circulating strains, but slow and limited production capacities increase the probability of vaccine mismatches. In contrast, DNA vaccination allows for rapid production of vaccines encoding novel influenza Ags. The efficacy of DNA vaccination is greatly improved if the DNA-encoded vaccine proteins target APCs. In this study, we have used hemagglutinin (HA) genes from each of six group 1 influenza viruses (H5, H6, H8, H9, H11, and H13), and inserted these into a DNA vaccine format that induces delivery of the HA protein Ags to MHC class II molecules on APCs. Each of the targeted DNA vaccines induced high titers of strain-specific anti-HA Abs. Importantly, when the six HA vaccines were mixed and injected simultaneously, the strain-specific Ab titers were maintained. In addition, the vaccine mixture induced Abs that cross-reacted with strains not included in the vaccine mixture (H1) and could protect mice against a heterosubtypic challenge with the H1 viruses A\/Puerto Rico\/8\/1934 (H1N1) and A\/California\/07\/2009 (H1N1). The data suggest that vaccination with a mixture of HAs could be useful for induction of strain-specific immunity against strains represented in the mixture and, in addition, confer some degree of cross-protection against unrelated influenza strains.<\/jats:p>","DOI":"10.4049\/jimmunol.1701088","type":"journal-article","created":{"date-parts":[[2018,2,13]],"date-time":"2018-02-13T15:06:13Z","timestamp":1518534373000},"page":"2057-2066","source":"Crossref","is-referenced-by-count":16,"title":["Simultaneous Targeting of Multiple Hemagglutinins to APCs for Induction of Broad Immunity against Influenza"],"prefix":"10.1093","volume":"200","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3776-8457","authenticated-orcid":false,"given":"Ane Marie","family":"Anderson","sequence":"first","affiliation":[{"name":"K.G. Jebsen Centre for Influenza Vaccine Research, Institute of Clinical Medicine , University of Oslo, 0027 Oslo,","place":["Norway"]},{"name":"Oslo University Hospital , 0027 Oslo,","place":["Norway"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Baranowska-Hustad","sequence":"additional","affiliation":[{"name":"K.G. Jebsen Centre for Influenza Vaccine Research, Institute of Clinical Medicine , University of Oslo, 0027 Oslo,","place":["Norway"]},{"name":"Oslo University Hospital , 0027 Oslo,","place":["Norway"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0451-5936","authenticated-orcid":false,"given":"Ranveig","family":"Braathen","sequence":"additional","affiliation":[{"name":"K.G. Jebsen Centre for Influenza Vaccine Research, Institute of Clinical Medicine , University of Oslo, 0027 Oslo,","place":["Norway"]},{"name":"Oslo University Hospital , 0027 Oslo,","place":["Norway"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunnveig","family":"Grodeland","sequence":"additional","affiliation":[{"name":"K.G. Jebsen Centre for Influenza Vaccine Research, Institute of Clinical Medicine , University of Oslo, 0027 Oslo,","place":["Norway"]},{"name":"Oslo University Hospital , 0027 Oslo,","place":["Norway"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bjarne","family":"Bogen","sequence":"additional","affiliation":[{"name":"K.G. Jebsen Centre for Influenza Vaccine Research, Institute of Clinical Medicine , University of Oslo, 0027 Oslo,","place":["Norway"]},{"name":"Oslo University Hospital , 0027 Oslo,","place":["Norway"]},{"name":"Centre for Immune Regulation, University of Oslo , 0027 Oslo,","place":["Norway"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,3,15]]},"reference":[{"key":"2025030610135233100_r1","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s11684-013-0275-1","article-title":"The first avian influenza A (H7N9) viral infection in humans in Zhejiang Province, China: a death report","volume":"7","author":"Chen","year":"2013","journal-title":"Front. Med."},{"key":"2025030610135233100_r2","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/jmv.24231","article-title":"Human infection with an avian influenza A (H9N2) virus in the middle region of China","volume":"87","author":"Huang","year":"2015","journal-title":"J. Med. Virol."},{"key":"2025030610135233100_r3","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jinf.2013.12.014","article-title":"Emergence in China of human disease due to avian influenza A(H10N8)--cause for concern?","volume":"68","author":"To","year":"2014","journal-title":"J. Infect."},{"key":"2025030610135233100_r4","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1056\/NEJMoa040419","article-title":"Avian influenza A (H5N1) in 10 patients in Vietnam","volume":"350","author":"Tran","year":"2004","journal-title":"New Engl. J. Med."},{"key":"2025030610135233100_r5","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S2213-2600(13)70221-2","article-title":"Human infection with avian influenza A H6N1 virus: an epidemiological analysis","volume":"1","author":"Wei","year":"2013","journal-title":"Lancet Respir. Med."},{"key":"2025030610135233100_r6","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.vaccine.2012.10.084","article-title":"Seasonal influenza vaccine efficacy and its determinants in children and non-elderly adults: a systematic review with meta-analyses of controlled trials","volume":"31","author":"DiazGranados","year":"2012","journal-title":"Vaccine"},{"key":"2025030610135233100_r7","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/1741-7015-11-153","article-title":"Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysis","volume":"11","author":"Tricco","year":"2013","journal-title":"BMC Med."},{"key":"2025030610135233100_r8","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1016\/j.vaccine.2010.04.083","article-title":"Global production of seasonal and pandemic (H1N1) influenza vaccines in 2009-2010 and comparison with previous estimates and global action plan targets","volume":"28","author":"Partridge","year":"2010","journal-title":"Vaccine"},{"key":"2025030610135233100_r9","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1056\/NEJMra1208802","article-title":"Pandemic preparedness and response--lessons from the H1N1 influenza of 2009","volume":"370","author":"Fineberg","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"2025030610135233100_r10","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1586\/erv.11.82","article-title":"The future of cell culture-based influenza vaccine production","volume":"10","author":"Perdue","year":"2011","journal-title":"Expert Rev. Vaccines"},{"key":"2025030610135233100_r11","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ymthe.2005.08.005","article-title":"Enhancement of cellular immune response to a prostate cancer DNA vaccine by intradermal electroporation","volume":"13","author":"Roos","year":"2006","journal-title":"Mol. Ther."},{"key":"2025030610135233100_r12","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1586\/14760584.2015.990890","article-title":"Electroporation-enhanced delivery of nucleic acid vaccines","volume":"14","author":"Broderick","year":"2015","journal-title":"Expert Rev. Vaccines"},{"key":"2025030610135233100_r13","first-page":"83","article-title":"Needle-free injection of DNA vaccines: a brief overview and methodology","volume":"127","author":"Raviprakash","year":"2006","journal-title":"Methods Mol. Med."},{"key":"2025030610135233100_r14","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1172\/JCI3986","article-title":"CD8 positive T cells influence antigen-specific immune responses through the expression of chemokines","volume":"102","author":"Kim","year":"1998","journal-title":"J. Clin. Invest."},{"key":"2025030610135233100_r15","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/gt.2015.86","article-title":"Intradermal delivery of DNA encoding HCV NS3 and perforin elicits robust cell-mediated immunity in mice and pigs","volume":"23","author":"Grubor-Bauk","year":"2016","journal-title":"Gene Ther."},{"key":"2025030610135233100_r16","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.ymthe.2005.10.019","article-title":"DNA vaccines increase immunogenicity of idiotypic tumor antigen by targeting novel fusion proteins to antigen-presenting cells","volume":"13","author":"Fredriksen","year":"2006","journal-title":"Mol. Ther."},{"key":"2025030610135233100_r17","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1182\/blood-2006-06-032938","article-title":"Chemokine-idiotype fusion DNA vaccines are potentiated by bivalency and xenogeneic sequences","volume":"110","author":"Fredriksen","year":"2007","journal-title":"Blood"},{"key":"2025030610135233100_r18","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.4049\/jimmunol.1300504","article-title":"DNA vaccine that targets hemagglutinin to MHC class II molecules rapidly induces antibody-mediated protection against influenza","volume":"191","author":"Grodeland","year":"2013","journal-title":"J. Immunol."},{"key":"2025030610135233100_r19","doi-asserted-by":"crossref","first-page":"e80008","DOI":"10.1371\/journal.pone.0080008","article-title":"The specificity of targeted vaccines for APC surface molecules influences the immune response phenotype","volume":"8","author":"Gr\u00f8deland","year":"2013","journal-title":"PLoS One"},{"key":"2025030610135233100_r20","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.vaccine.2010.10.057","article-title":"Human chemokine MIP1\u03b1 increases efficiency of targeted DNA fusion vaccines","volume":"29","author":"Ruffini","year":"2010","journal-title":"Vaccine"},{"key":"2025030610135233100_r21","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.4049\/jimmunol.1600893","article-title":"Antigen targeting to human HLA class II molecules increases efficacy of DNA vaccination","volume":"197","author":"Grodeland","year":"2016","journal-title":"J. Immunol."},{"key":"2025030610135233100_r22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/327059a0","article-title":"Adjuvant-free IgG responses induced with antigen coupled to antibodies against class II MHC","volume":"327","author":"Carayanniotis","year":"1987","journal-title":"Nature"},{"key":"2025030610135233100_r23","doi-asserted-by":"crossref","first-page":"58","DOI":"10.4049\/jimmunol.136.1.58","article-title":"Enhancement of antigenic potency in vitro and immunogenicity in vivo by coupling the antigen to anti-immunoglobulin","volume":"136","author":"Kawamura","year":"1986","journal-title":"J. Immunol."},{"key":"2025030610135233100_r24","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.4049\/jimmunol.139.5.1609","article-title":"Targeted antigen presentation using crosslinked antibody heteroaggregates","volume":"139","author":"Snider","year":"1987","journal-title":"J. Immunol."},{"key":"2025030610135233100_r25","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3389\/fimmu.2015.00367","article-title":"Polarizing T and B cell responses by APC-targeted subunit vaccines","volume":"6","author":"Gr\u00f8deland","year":"2015","journal-title":"Front. Immunol."},{"key":"2025030610135233100_r26","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/eji.201445080","article-title":"Vaccine molecules targeting Xcr1 on cross-presenting DCs induce protective CD8+ T-cell responses against influenza virus","volume":"45","author":"Fossum","year":"2015","journal-title":"Eur. J. Immunol."},{"key":"2025030610135233100_r27","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3389\/fonc.2012.00154","article-title":"Targeted DNA vaccines for enhanced induction of idiotype-specific B and T cells","volume":"2","author":"Fredriksen","year":"2012","journal-title":"Front. Oncol."},{"key":"2025030610135233100_r28","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1586\/14760584.2015.1029919","article-title":"Efficient vaccine against pandemic influenza: combining DNA vaccination and targeted delivery to MHC class II molecules","volume":"14","author":"Gr\u00f8deland","year":"2015","journal-title":"Expert Rev. Vaccines"},{"key":"2025030610135233100_r29","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0022-1759(97)00034-3","article-title":"Versatile vectors for transient and stable expression of recombinant antibody molecules in mammalian cells","volume":"204","author":"Norderhaug","year":"1997","journal-title":"J. Immunol. Methods"},{"key":"2025030610135233100_r30","doi-asserted-by":"crossref","first-page":"e7226","DOI":"10.1371\/journal.pone.0007226","article-title":"Skin electroporation: effects on transgene expression, DNA persistence and local tissue environment","volume":"4","author":"Roos","year":"2009","journal-title":"PLoS One"},{"key":"2025030610135233100_r31","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/S0264-410X(00)00395-9","article-title":"Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans","volume":"19","author":"Treanor","year":"2001","journal-title":"Vaccine"},{"key":"2025030610135233100_r32","doi-asserted-by":"crossref","first-page":"7639","DOI":"10.1073\/pnas.78.12.7639","article-title":"Sequence relationships among the hemagglutinin genes of 12 subtypes of influenza A virus","volume":"78","author":"Air","year":"1981","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025030610135233100_r33","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/35078099","article-title":"B cells acquire antigen from target cells after synapse formation","volume":"411","author":"Batista","year":"2001","journal-title":"Nature"},{"key":"2025030610135233100_r34","doi-asserted-by":"crossref","first-page":"13463","DOI":"10.1128\/JVI.05193-11","article-title":"Complement-dependent lysis of influenza a virus-infected cells by broadly cross-reactive human monoclonal antibodies","volume":"85","author":"Terajima","year":"2011","journal-title":"J. Virol."},{"key":"2025030610135233100_r35","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/infdis\/148.5.785","article-title":"Antibody-dependent cell-mediated cytotoxicity against influenza virus-infected cells","volume":"148","author":"Hashimoto","year":"1983","journal-title":"J. Infect. Dis."},{"key":"2025030610135233100_r36","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1128\/iai.20.3.640-645.1978","article-title":"Lymphocyte cytotoxicity to influenza virus-infected cells: response to vaccination and virus infection","volume":"20","author":"Greenberg","year":"1978","journal-title":"Infect. Immun."},{"key":"2025030610135233100_r37","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nm.3443","article-title":"Broadly neutralizing hemagglutinin stalk-specific antibodies require Fc\u03b3R interactions for protection against influenza virus in vivo","volume":"20","author":"DiLillo","year":"2014","journal-title":"Nat. Med."},{"key":"2025030610135233100_r38","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.4049\/jimmunol.1201574","article-title":"Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity antibodies in the absence of neutralizing antibodies","volume":"190","author":"Jegaskanda","year":"2013","journal-title":"J. Immunol."},{"key":"2025030610135233100_r39","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/273238a0","article-title":"Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus","volume":"273","author":"Yap","year":"1978","journal-title":"Nature"},{"key":"2025030610135233100_r40","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/267354a0","article-title":"Cytotoxic T cells kill influenza virus infected cells but do not distinguish between serologically distinct type A viruses","volume":"267","author":"Zweerink","year":"1977","journal-title":"Nature"},{"key":"2025030610135233100_r41","doi-asserted-by":"crossref","first-page":"9404","DOI":"10.1128\/JVI.72.11.9404-9406.1998","article-title":"Definition of amino acid residues on the epitope responsible for recognition by influenza A virus H1-specific, H2-specific, and H1- and H2-cross-reactive murine cytotoxic T-lymphocyte clones","volume":"72","author":"Tamura","year":"1998","journal-title":"J. Virol."},{"key":"2025030610135233100_r42","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/nm.2612","article-title":"Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans","volume":"18","author":"Wilkinson","year":"2012","journal-title":"Nat. Med."},{"key":"2025030610135233100_r43","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/cmi.2016.20","article-title":"Identification of a CD4 T-cell epitope in the hemagglutinin stalk domain of pandemic H1N1 influenza virus and its antigen-driven TCR usage signature in BALB\/c mice","volume":"14","author":"Lu","year":"2017","journal-title":"Cell. Mol. Immunol."}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/200\/6\/2057\/61513007\/ji1701088.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/200\/6\/2057\/61513007\/ji1701088.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T10:27:57Z","timestamp":1741256877000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/200\/6\/2057\/7962266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,3,15]]}},"URL":"https:\/\/doi.org\/10.4049\/jimmunol.1701088","relation":{},"ISSN":["0022-1767","1550-6606"],"issn-type":[{"value":"0022-1767","type":"print"},{"value":"1550-6606","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,3]]},"published":{"date-parts":[[2018,3]]}}}